Literature DB >> 164658

Contribution of the peptide backbone to the action of oxytocin analogs.

O Hechter, T Kato, S H Nakagawa, F Yang, G Flouret.   

Abstract

This investigation was undertaken to evaluate the functional contribution of the peptide backbone of oxytocin in its interaction with receptor. Corey-Pauling-Koltun models of (Gly-7) deaminooxytocin, deaminotocinamide, and their respective retro-D-analogs built in any specific conformation (e.g., the Walter-Urry model for oxytocin) have a quai-equivalent topochemical arrangement of amino-acid side chains; however, the CO and NH elements of the peptide backbone of the retro-D-analog are reversed. The retro-D-analogs of deaminotocinamide and (Gly-7) deaminooxytocin (prepared using D-alle for L-Ile) and their respective N-formyl derivatives were assayed for uterotonic activity relative to related L-peptides. All retro-D-analogs (tested at concentrations ranging from 10-10 to 10-5 M) were devoid of angonistic (or antagonistic) activity in the isolated rat uterus, except for the retro-D-(D-alle-3, Gly-7) deaminooxytocinamine, which retains a terminal NH-2 group on the tail; the latter is a partial agonist with very low affinity. The results obtained with retro-D-analogs indicate that one or more of the elements of the peptide backbone of the tocinamide ring are essential for "occupation" and "activation" of uterine receptors. Oxytocin action may be the resultant of multiple hydrogen-bonding interactions between CO, NH, NH-2, and OH groups of the hormone with complementary groups on receptor, made possible by appropriate hydrophobic bonding.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164658      PMCID: PMC432353          DOI: 10.1073/pnas.72.2.563

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  PARTITION CHROMATOGRAPHY OF OXYTOCIN ON 'SEPHADEX'.

Authors:  D YAMASHIRO
Journal:  Nature       Date:  1964-01-04       Impact factor: 49.962

2.  Synthesis of peptides by aminolysis of nitrophenyl esters.

Authors:  M BODANSZKY
Journal:  Nature       Date:  1955-04-16       Impact factor: 49.962

3.  Effect of magnesium ion on the response of the rat uterus to neurohypophysial hormones and analogues.

Authors:  R A MUNSICK
Journal:  Endocrinology       Date:  1960-03       Impact factor: 4.736

4.  Gel filtration: a method for desalting and group separation.

Authors:  J PORATH; P FLODIN
Journal:  Nature       Date:  1959-06-13       Impact factor: 49.962

5.  Principles of hormone action: the problem of molecular linguistics.

Authors:  O Hechter; A Calek
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1974

6.  300-MHz nuclear magnetic resonance study of oxytocin aqueous solution: conformational implications.

Authors:  A I Brewster; V J Hruby
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

7.  A neurohypophyseal hormone analog with selective oxytocin-like activities and resistance to enzymatic inactivation: an approach to the design of peptide drugs.

Authors:  R Walter; T Yamanaka; S Sakakibara
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

8.  Model-building of neurohypophyseal hormones.

Authors:  B Honig; E A Kabat; L Katz; C Levinthal; T T Wu
Journal:  J Mol Biol       Date:  1973-10-25       Impact factor: 5.469

9.  Symmetrical disulfide bonds as S-protecting groups and their cleavage by dithiothreitol: synthesis of oxytocin with high biological activity.

Authors:  S Hase; R Walter
Journal:  Int J Pept Protein Res       Date:  1973

10.  Topochemical investigations of peptide systems.

Authors:  M M Shemyakin; Y A Ovchinnikov; V T Ivanov
Journal:  Angew Chem Int Ed Engl       Date:  1969-07       Impact factor: 15.336

View more
  1 in total

1.  Biofunctional evaluation of a hydrogen bond linking the ring and tail beta-turns of oxytocin.

Authors:  J Roy; U Roy; D C Gazis; I L Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.